GlassScriptPhysician profile
Gerame T Wells
NPI 1851436646
$1,266.40
in general payments reported to CMS, 2019-2025
11 companies · $994 in 2025
The $994 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.09 · 2020: $12.87 · 2021: $71.36 · 2022: $37.23 · 2023: $22.66 · 2024: $39.64 · 2025: $994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $582 · Food and Beverage: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $581.85 |
| Food and Beverage | $474.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $773.21 | 2024-2025 | Overstitch Endoscopic Suturing System |
| Organogenesis INC. | $196.20 | 2019-2025 | Affinity, Apligraf |
| Phathom Pharmaceuticals, INC. | $86.53 | 2025 | Voquezna |
| Ethicon US, LLC | $79.78 | 2019-2025 | N/A |
| Olympus America INC. | $50.41 | 2021-2023 | 4k Cable 8.5m |
| Kerecis Limited | $17.52 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Davol INC. | $13.20 | 2022 | |
| Allergan, INC. | $12.87 | 2020 | |
| Smith+Nephew, INC. | $12.65 | 2021 | |
| Avanos Medical | $12.27 | 2022 | |
| Kci USA, INC. | $11.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerame Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.